Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 151
Filter
1.
Eur J Histochem ; 67(4)2023 Oct 10.
Article in English | MEDLINE | ID: mdl-37817677

ABSTRACT

Platelet-rich plasma (PRP) is gaining more and more attention in regenerative medicine as an innovative and efficient therapeutic approach. The regenerative properties of PRP rely on the numerous bioactive molecules released by the platelets: growth factors are involved in proliferation and differentiation of endothelial cells and fibroblasts, angiogenesis and extracellular matrix formation, while cytokines are mainly involved in immune cell recruitment and inflammation modulation. Attempts are ongoing to improve the therapeutic potential of PRP by combining it with agents able to promote regenerative processes. Two interesting candidates are ozone, administered at low doses as gaseous oxygen-ozone mixtures, and procaine. In the present study, we investigated the effects induced on platelets by the in vitro treatment of PRP with ozone or procaine, or both. We combined transmission electron microscopy to obtain information on platelet modifications and bioanalytical assays to quantify the secreted factors. The results demonstrate that, although platelets were already activated by the procedure to prepare PRP, both ozone and procaine induced differential morpho-functional modifications in platelets resulting in an increased release of factors. In detail, ozone induced an increase in surface protrusions and open canalicular system dilation suggestive of a marked α-granule release, while procaine caused a decrease in surface protrusions and open canalicular system dilation but a remarkable increase in microvesicle release suggestive of high secretory activity. Consistently, nine of the thirteen platelet-derived factors analysed in the PRP serum significantly increased after treatment with ozone and/or procaine. Therefore, ozone and procaine proved to have a remarkable stimulating potential without causing any damage to platelets, probably because they act through physiological, although different, secretory pathways.


Subject(s)
Ozone , Platelet-Rich Plasma , Ozone/pharmacology , Procaine/pharmacology , Procaine/metabolism , Endothelial Cells , Cytokines/metabolism , Platelet-Rich Plasma/metabolism
2.
J Biochem Mol Toxicol ; 36(9): e23136, 2022 Sep.
Article in English | MEDLINE | ID: mdl-35678294

ABSTRACT

Methylmercury (MeHg) is a cumulative environmental pollutant that can easily cross the blood-brain barrier and cause damage to the brain, mainly targeting the central nervous system. The purpose of this study is to investigate the role of calcium ion (Ca2+ ) homeostasis between the endoplasmic reticulum (ER) and mitochondria in MeHg-induced neurotoxicity. Rat primary cortical neurons exposed to MeHg (0.25-1 µm) underwent dose-dependent cell damage, accompanied by increased Ca2+ release from the ER and elevated levels of free Ca2+ in cytoplasm and mitochondria. MeHg also increased the protein and messenger RNA expressions of the inositol 1,4,5-triphosphate receptor, ryanodine receptor 2, and mitochondrial calcium uniporter. Ca2+ channel inhibitors 2-aminoethyl diphenylborinate and procaine reduced the release of Ca2+ from ER, while RR and 4,4'-diisothiocyanatostilbene-2,2'-disulfonate inhibited Ca2+ uptake from mitochondria. In addition, pretreatment with Ca2+ chelator BAPTA-AM effectively restored mitochondrial membrane potential levels, inhibited over opening of mitochondrial permeability transition pore, and maintained mitochondrial function stability. Meanwhile, the expression of mitochondrial apoptosis-related proteins recovered to some extent, along with the reduction of the early apoptosis ratio. These results suggest that Ca2+ homeostasis plays an essential role in mitochondrial damage and apoptosis induced by MeHg, which may be one of the important mechanisms of MeHg-induced neurotoxicity.


Subject(s)
Environmental Pollutants , Methylmercury Compounds , Animals , Apoptosis , Calcium/metabolism , Chelating Agents , Endoplasmic Reticulum , Environmental Pollutants/pharmacology , Homeostasis , Inositol 1,4,5-Trisphosphate Receptors/metabolism , Inositol 1,4,5-Trisphosphate Receptors/pharmacology , Methylmercury Compounds/metabolism , Methylmercury Compounds/toxicity , Mitochondria/metabolism , Mitochondrial Permeability Transition Pore , Neurons/metabolism , Procaine/metabolism , Procaine/pharmacology , RNA, Messenger/metabolism , Rats , Ryanodine Receptor Calcium Release Channel/metabolism , Ryanodine Receptor Calcium Release Channel/pharmacology
3.
Int J Mol Sci ; 21(18)2020 Sep 04.
Article in English | MEDLINE | ID: mdl-32899772

ABSTRACT

To ameliorate ischemia-induced graft injury, optimal organ preservation remains a critical hallmark event in solid organ transplantation. Although numerous preservation solutions are in use, they still have functional limitations. Here, we present a concise review of a modified Histidine-Tryptophan-Ketoglutarate (HTK) solution, named HTK-N. Its composition differs from standard HTK solution, carrying larger antioxidative capacity and providing inherent toxicity as well as improved tolerance to cold aiming to attenuate cold storage injury in organ transplantation. The amino acids glycine, alanine and arginine were supplemented, N-acetyl-histidine partially replaced histidine, and aspartate and lactobionate substituted chloride. Several in vitro studies confirmed the superiority of HTK-N in comparison to HTK, being tested in vivo in animal models for liver, kidney, pancreas, small bowel, heart and lung transplantation to adjust ingredients for required conditions, as well as to determine its innocuousness, applicability and potential advantages. HTK-N solution has proven to be advantageous especially in the preservation of liver and heart grafts in vivo and in vitro. Thus, ongoing clinical trials and further studies in large animal models and consequently in humans are inevitable to show its ability minimizing ischemia-induced graft injury in the sequel of organ transplantation.


Subject(s)
Organ Preservation Solutions/chemistry , Organ Preservation/methods , Alanine , Animals , Arginine , Cryopreservation/methods , Glucose/chemistry , Glucose/metabolism , Glycine , Humans , Liver/drug effects , Mannitol/chemistry , Mannitol/metabolism , Organ Transplantation , Pancreas/drug effects , Potassium Chloride/chemistry , Potassium Chloride/metabolism , Procaine/chemistry , Procaine/metabolism , Reperfusion Injury
4.
Sci Rep ; 9(1): 13897, 2019 09 25.
Article in English | MEDLINE | ID: mdl-31554887

ABSTRACT

Normothermic machine perfusion (NMP) of kidney grafts is a promising new preservation method to improve graft quality and clinical outcome. Routinely, kidneys are washed out of blood remnants and cooled using organ preservation solutions prior to NMP. Here we assessed the effect of cold preflush compared to direct NMP. After 30 min of warm ischemia, porcine kidneys were either preflushed with cold histidine-tryptophan-ketoglutarate solution (PFNMP group) prior to NMP or directly subjected to NMP (DNMP group) using a blood/buffer solution. NMP was performed at a perfusion pressure of 75 mmHg for 6 h. Functional parameters were assessed as well as histopathological and biochemical analyses. Renal function as expressed by creatinine clearance, fractional excretion of sodium and total output of urine was inferior in PFNMP. Urine protein and neutrophil gelatinase-associated lipocalin (NGAL) concentrations as markers for kidney damage were significantly higher in the PFNMP group. Additionally, increased osmotic nephropathy was found after PFNMP. This study demonstrated that cold preflush prior to NMP aggravates ischemia reperfusion injury in comparison to direct NMP of warm ischemia-damaged kidney grafts. With increasing use of NMP systems for kidneys and other organs, further research into graft flushing during retrieval is warranted.


Subject(s)
Kidney/metabolism , Organ Preservation Solutions/metabolism , Reperfusion Injury/metabolism , Animals , Female , Glucose/metabolism , Kidney Transplantation/methods , Lipocalin-2/metabolism , Mannitol/metabolism , Models, Animal , Organ Preservation/methods , Perfusion/methods , Potassium Chloride/metabolism , Procaine/metabolism , Swine , Warm Ischemia/methods
5.
Best Pract Res Clin Anaesthesiol ; 32(2): 179-185, 2018 Jun.
Article in English | MEDLINE | ID: mdl-30322458

ABSTRACT

Local anesthetics are used for performing various regional anesthesia techniques to provide intraoperative anesthesia and analgesia, as well as for the treatment of acute and chronic pain. Older medications such as lidocaine and bupivacaine as well as newer ones such as mepivacaine and ropivacaine are being used successfully for decades. Routes of administration include neuraxial, perineural, intravenous, various infiltrative approaches, topical, and transdermal. There are new innovations with the use of older local anesthetics in a novel manner, in addition to the development and use of new formulations. This chapter seeks to summarize the pharmacokinetics of local anesthetics and address the role of newer local anesthetics, as well as clinical implications, safety profiles, and the future of local anesthetic research. Finally, some clinical pearls are highlighted.


Subject(s)
Anesthesia, Local/trends , Anesthetics, Local/administration & dosage , Anesthesia, Local/methods , Anesthetics, Local/metabolism , Bupivacaine/administration & dosage , Bupivacaine/metabolism , Drug Administration Routes , Humans , Lidocaine/administration & dosage , Lidocaine/metabolism , Mepivacaine/administration & dosage , Mepivacaine/metabolism , Procaine/administration & dosage , Procaine/analogs & derivatives , Procaine/metabolism , Sodium Channel Blockers/administration & dosage , Sodium Channel Blockers/metabolism
6.
Eur Biophys J ; 46(3): 265-282, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27557558

ABSTRACT

Despite available experimental results, the molecular mechanism of action of local anesthetics upon the nervous system and contribution of the cell membrane to the process are still controversial. In this work, molecular dynamics simulations were performed to investigate the effect of two clinically used local anesthetics, procaine and tetracaine, on the structure and dynamics of a fully hydrated dimyristoylphosphatidylcholine lipid bilayer. We focused on comparing the main effects of uncharged and charged drugs on various properties of the lipid membrane: mass density distribution, diffusion coefficient, order parameter, radial distribution function, hydrogen bonding, electrostatic potential, headgroup angle, and water dipole orientation. To compare the diffusive nature of anesthetic through the lipid membrane quantitatively, we investigated the hexadecane/water partition coefficient using expanded ensemble simulation. We predicted the permeability coefficient of anesthetics in the following order: uncharged tetracaine > uncharged procaine > charged tetracaine > charged procaine. We also shown that the charged forms of drugs are more potent in hydrogen bonding, disturbing the lipid headgroups, changing the orientation of water dipoles, and increasing the headgroup electrostatic potential more than uncharged drugs, while the uncharged drugs make the lipid diffusion faster and increase the tail order parameter. The results of these simulation studies suggest that the different forms of anesthetics induce different structural modifications in the lipid bilayer, which provides new insights into their molecular mechanism.


Subject(s)
Anesthetics, Local/metabolism , Anesthetics, Local/pharmacology , Lipid Bilayers/metabolism , Procaine/metabolism , Procaine/pharmacology , Tetracaine/metabolism , Tetracaine/pharmacology , Anesthetics, Local/chemistry , Cell Membrane/chemistry , Cell Membrane/drug effects , Cell Membrane/metabolism , Diffusion , Dimyristoylphosphatidylcholine/metabolism , Lipid Bilayers/chemistry , Molecular Conformation , Molecular Dynamics Simulation , Procaine/chemistry , Tetracaine/chemistry , Thermodynamics
7.
Eur J Anaesthesiol ; 31(11): 575-85, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25192265

ABSTRACT

This review seeks to address 10 essential questions regarding the clinical use of local anaesthetics. Each local anaesthetic has distinctive physicochemical properties but with the same mode of action; they block voltage-gated sodium channels in the axon. Sodium channel block is brought about by a conformational change and the creation of a positive charge in the channel pore. Different local anaesthetics can reach the local anaesthetic binding site in the axon from the cytoplasmic compartment (classic hydrophilic pathway), or directly via its lipid membrane (hydrophobic pathway), or can enter via large-pore channels (alternative hydrophilic pathway). Beyond the nervous system, local anaesthetics exert beneficial effects on pain and can affect the inflammatory response and the haemostatic system. There are problems with the efficacy of local anaesthetics in the presence of local inflammation, and with significant intravascular toxicity, which can be fatal. But when preventive measures are taken, the incidence of cardiac arrest is low. Intralipid has been proposed to treat systemic local anaesthetic overdose and has been enthusiastically adopted worldwide, even though the mechanism of action is incompletely understood. Intralipid is an aid to the management of local anaesthetic toxicity rather than an antidote and meticulous conduct of regional anaesthesia remains paramount. All local anaesthetics are toxic, in a dose- and time-dependent manner, on virtually all tissues, including nerves and muscles. The question of whether local anaesthetics protect against perioperative tumour progression cannot be answered at this moment, and results from clinical (retrospective) studies are equivocal. Future areas of interest will be the design of new subtype-specific sodium channel blockers, but as we look forward, older local anaesthetics such as 2-chloroprocaine are being reintroduced into the clinical setting. Multimodal perineural analgesia and liposomal bupivacaine may replace catheter techniques for some indications.


Subject(s)
Anesthetics, Local/administration & dosage , Anesthetics, Local/metabolism , Voltage-Gated Sodium Channel Blockers/administration & dosage , Voltage-Gated Sodium Channel Blockers/metabolism , Anesthetics, Local/adverse effects , Animals , Bupivacaine/administration & dosage , Bupivacaine/adverse effects , Bupivacaine/metabolism , Dose-Response Relationship, Drug , Humans , Inflammation/chemically induced , Inflammation/metabolism , Inflammation/prevention & control , Lipid Metabolism/drug effects , Lipid Metabolism/physiology , Procaine/administration & dosage , Procaine/adverse effects , Procaine/analogs & derivatives , Procaine/metabolism , Time Factors , Voltage-Gated Sodium Channel Blockers/adverse effects
8.
Article in Russian | MEDLINE | ID: mdl-23718080

ABSTRACT

This study has demonstrated the effectiveness of a 2% procaine solution given with a view to improving metabolic parameters of aging, such as the body weight and composition along with the lipid profile in the patients varying in age from 30 years to 75 years. The study involved 95 patients treated with a 2% procaine solution that was administered by different methods (electrophoresis and mesotherapy) into several points of the collar region and upper back. The control group was comprised of the patients who received placebo by means of galvanization and mesotherapy. The results of the study indicate that the introduction of a 2% procaine solution in the treatment of metabolic disorders effectively improves selected metabolic characteristics of ageing and thereby helps to reduce the biological age in comparison with the control patients treated with placebo.


Subject(s)
Aging/drug effects , Mesotherapy/methods , Procaine/therapeutic use , Adult , Aged , Aging/metabolism , Anthropometry , Body Composition/drug effects , Body Weight/drug effects , Data Interpretation, Statistical , Electrodes , Female , Humans , Iontophoresis , Lipid Metabolism/drug effects , Male , Middle Aged , Procaine/administration & dosage , Procaine/metabolism , Treatment Outcome
9.
Biochim Biophys Acta ; 1818(12): 3010-8, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22842001

ABSTRACT

The membrane location of the local anesthetics (LA) lidocaine, dibucaine, tetracaine, and procaine hydrochloride as well as their influence on phospholipid bilayers were studied by ³¹P and ¹H magic-angle spinning (MAS) NMR spectroscopy. The ³¹P NMR spectra of the LA/lipid preparations confirmed that the overall bilayer structure of the membrane remained preserved. The relation between the molecular structure of the LAs and their membrane localization and orientation was investigated quantitatively using induced chemical shifts, nuclear Overhauser enhancement spectroscopy, and paramagnetic relaxation rates. All three methods revealed an average location of the aromatic rings of all LAs in the lipid-water interface of the membrane, with small differences between the individual LAs depending on their molecular properties. While lidocaine is placed in the upper chain/glycerol region of the membrane, for dibucaine and procaine the maximum of the distribution are slightly shifted into the glycerol region. Finally for tetracaine the aromatic ring is placed closest to the aqueous phase in the glycerol/headgroup region of the membrane. The hydrophobic side chains of the LA molecules dibucaine and tetracaine were located deeper in the membrane and showed an orientation towards the hydrocarbon core. In contrast the side chains of lidocaine and procaine are oriented towards the aqueous phase.


Subject(s)
Anesthetics, Local/metabolism , Cell Membrane/metabolism , Lipid Bilayers/chemistry , Lipid Bilayers/metabolism , Cell Membrane/ultrastructure , Dibucaine/metabolism , Hydrophobic and Hydrophilic Interactions , Lidocaine/metabolism , Magnetic Resonance Spectroscopy , Procaine/metabolism , Tetracaine/metabolism
10.
Drug Metab Dispos ; 35(11): 2015-22, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17664252

ABSTRACT

The capacity of human, minipig, and rat skin and liver subcellular fractions to hydrolyze the anesthetic ester procaine was compared with carboxylesterase substrates 4-methylumbelliferyl-acetate, phenylvalerate, and para-nitrophenylacetate and the arylesterase substrate phenylacetate. Rates of procaine hydrolysis by minipig and human skin microsomal and cytosolic fractions were similar, with rat displaying higher activity. Loperamide inhibited procaine hydrolysis by human skin, suggesting involvement of human carboxylesterase hCE2. The esterase activity and inhibition profiles in the skin were similar for minipig and human, whereas rat had a higher capacity to metabolize esters and a different inhibition profile. Minipig and human liver and skin esterase activity was inhibited principally by paraoxon and bis-nitrophenyl phosphate, classical carboxylesterase inhibitors. Rat skin and liver esterase activity was inhibited additionally by phenylmethylsulfonyl fluoride and the arylesterase inhibitor mercuric chloride, indicating a different esterase profile. These results have highlighted the potential of skin to hydrolyze procaine following topical application, which possibly limits its pharmacological effect. Skin from minipig used as an animal model for assessing transdermal drug preparations had similar capacity to hydrolyze esters to human skin.


Subject(s)
Esterases/metabolism , Liver/enzymology , Procaine/metabolism , Skin/enzymology , Animals , Enzyme Inhibitors/pharmacology , Esterases/antagonists & inhibitors , Esters , Female , Humans , Hydrolysis/drug effects , Loperamide/pharmacology , Male , Microsomes, Liver/drug effects , Microsomes, Liver/enzymology , Microsomes, Liver/metabolism , Molecular Structure , Nitrophenols/chemistry , Nitrophenols/metabolism , Nitrophenols/pharmacology , Paraoxon/pharmacology , Pentanoic Acids/chemistry , Pentanoic Acids/metabolism , Phenylacetates/chemistry , Phenylacetates/metabolism , Phenylmethylsulfonyl Fluoride/pharmacology , Procaine/chemistry , Procaine/pharmacokinetics , Rats , Rats, Wistar , Swine , Swine, Miniature , Umbelliferones/chemistry , Umbelliferones/metabolism
11.
Anal Chem ; 79(18): 6949-58, 2007 Sep 15.
Article in English | MEDLINE | ID: mdl-17688323

ABSTRACT

A new third-order multivariate calibration approach, based on the combination of multiway-partial least-squares with a separate procedure called residual trilinearization (N-PLS/RTL), is presented and applied to multicomponent analysis using third-order data. The proposed chemometric algorithm is able to predict analyte concentrations in the presence of unexpected sample components, which require strict adherence to the second-order advantage. Results for the determination of procaine and its metabolite p-aminobenzoic acid in equine serum are discussed, based on kinetic fluorescence excitation-emission four-way measurements and application of the newly developed multiway methodology. Since the analytes are also the reagent and product of the hydrolysis reaction followed by fast-scanning fluorescence spectroscopy, the classical approach based on parallel factor analysis is challenged by strong linear dependencies and multilinearity losses. In comparison, N-PLS/RTL appears an appealing genuine multiway alternative that avoids the latter complications, yielding analytical results that are statistically comparable to those rendered by related unfolded algorithms, which are also able to process four-way data. Prediction was made on validation samples with a qualitative composition similar to the calibration set and also on test samples containing unexpected equine serum components.


Subject(s)
4-Aminobenzoic Acid/analysis , Anesthetics, Local/analysis , Models, Chemical , Procaine/analysis , Serum/chemistry , 4-Aminobenzoic Acid/chemistry , Anesthetics, Local/metabolism , Animals , Horses , Kinetics , Least-Squares Analysis , Procaine/metabolism , Spectrometry, Fluorescence
12.
J Chromatogr A ; 1154(1-2): 368-72, 2007 Jun 22.
Article in English | MEDLINE | ID: mdl-17507024

ABSTRACT

Capillary electrophoresis with electrochemiluminescene detection was used to characterize procaine hydrolysis as a probe for butyrylcholinesterase by in vitro procaine metabolism in plasma with butyrylcholinesterase acting as bioscavenger. Procaine and its metabolite N,N-diethylethanolamine were separated at 16 kV and then detected at 1.25 V in the presence of 5.0 mM Ru(bpy)(3)2+, with the detection limits of 2.4x10(-7) and 2.0x10(-8) mol/L (S/N=3), respectively. The Michaelis constant Km value was 1.73x10(-4) mol/L and the maximum velocity Vmax was 1.62x10(-6) mol/L/min. Acetylcholine bromide and choline chloride presented inhibition effects on the enzymatic cleavage of procaine, with the 50% inhibition concentration (IC50) of 6.24x10(-3) and 2.94x10(-4) mol/L.


Subject(s)
Butyrylcholinesterase/analysis , Electrophoresis, Capillary/methods , Ethanolamines/analysis , Luminescent Measurements/methods , Procaine/analysis , Procaine/metabolism , Acetylcholine/pharmacology , Butyrylcholinesterase/metabolism , Choline/pharmacology , Cholinesterase Inhibitors/pharmacology , Electrochemistry , Humans , Organometallic Compounds , Reproducibility of Results , Sensitivity and Specificity
13.
Anal Bioanal Chem ; 385(4): 737-41, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16598455

ABSTRACT

An automated procedure for the assay of procaine hydrochloride in human blood and pharmaceuticals was developed using a sequential injection (SI) technique with fluorometric detection and fluorescamine as the fluorescence probe. A few microliters of fluorescamine and procaine hydrochloride solutions were used in the SI system leading to the formation of a derivative, which was then excited by a 400-nm LED and whose emitted fluorescence was monitored at a wavelength of 494 nm. A linear calibration graph was obtained with 10-200 ng mL(-1) (procaine) by loading 10.0 microL of sample solution and 5.0 microL of fluorescamine solution (both 0.125 % m/v). A detection limit of 2.6 ng mL(-1), defined as 3 times the blank standard deviation (3sigma), was achieved along with a sampling frequency of 25 h(-1) and a precision of 2.1 % RSD at the 50.0 ng mL(-1) level. Procaine contents in injection solutions from various pharmaceutical manufactures were analyzed and reasonable agreement was achieved between the values obtained by using the present procedure and the documented spectrophotometry, and both were coincident with the nominal concentrations. In addition, the degradation of procaine in human blood was investigated. A fast degradation of procaine in human blood was observed for the first 30 min, while afterwards the degradation was retarded.


Subject(s)
Fluorometry/methods , Pharmaceutical Preparations/chemistry , Procaine/analysis , Procaine/blood , Buffers , Humans , Hydrogen-Ion Concentration , Procaine/metabolism , Solutions , Solvents
15.
Invest New Drugs ; 22(1): 3-16, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14707490

ABSTRACT

Cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N(4)]-chloride platinum (II) monohydrochloride monohydrate (DPR) is a new platinum triamine complex obtained from the synthesis of cisplatin and procaine. In this paper we analyzed, adopting a disease-oriented strategy, the tumour selectivity of this compound, its ability to induce apoptosis and its mechanism of interaction with DNA. The inhibition of cell proliferation was evaluated by the MTT assay using a panel of 51 tumour cell lines. Some of them were also evaluated for the induction of apoptosis by 4'-6-diamidine-2'-phenylindole (DAPI) staining, Western blot of p53 protein and agarose gel electrophoresis of ladder DNA. Finally, interstand cross-links (ISCL) were evaluated by ethidium bromide fluorescence technique. When evaluated by the MTT assay, DPR showed a high selective activity for neuroblastoma, small cell lung cancer (SCLC), ovarian cancer and leukemia cell lines. The comparison of mean graphs of DPR and cisplatin suggested that our compound possesses a mechanism of action similar to that, at least in part, of its parent compound. Moreover, DPR showed itself to be a good trigger of programmed cell death, as demonstrated by DAPI staining, activation of p53 protein and agarose gel electrophoresis of ladder DNA. Finally, the study of the formation of ISCLs demonstrated that DPR, despite being a monofunctional platinum compound, is able to form bifunctional adducts through the release of procaine residue. Data presented here suggest that DPR is an antitumour agent able to trigger apoptosis, and that it is endowed with a peculiar mechanism(s) of action and a special selective activity against two tumours, namely neuroblastoma and SCLC, which are still characterized by a low incidence of long-term survivors.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Cisplatin/analogs & derivatives , Cisplatin/pharmacology , Organoplatinum Compounds/pharmacology , Procaine/analogs & derivatives , Procaine/pharmacology , Animals , Apoptosis/genetics , Cell Line, Tumor , Cell Survival/drug effects , DNA Fragmentation , Drug Evaluation, Preclinical , Drug Screening Assays, Antitumor , Electrophoresis, Agar Gel , Fluorescent Dyes , Humans , Indoles/pharmacology , Inhibitory Concentration 50 , Mice , Microscopy, Fluorescence , Procaine/metabolism , Tumor Suppressor Protein p53/biosynthesis , Tumor Suppressor Protein p53/genetics , Up-Regulation
16.
Cancer Res ; 63(16): 4984-9, 2003 Aug 15.
Article in English | MEDLINE | ID: mdl-12941824

ABSTRACT

Methylation-associated silencing of tumor suppressor genes is recognized as being a molecular hallmark of human cancer. Unlike genetic alterations, changes in DNA methylation are potentially reversible. This possibility has attracted considerable attention from a therapeutics standpoint. Nucleoside-analogue inhibitors of DNA methyltransferases, such as 5-aza-2'-deoxycytidine, are able to demethylate DNA and restore silenced gene expression. Unfortunately, the clinical utility of these compounds has not yet been fully realized, mainly because of their side effects. A few non-nucleoside inhibitors of DNA methyltransferases have been reported, including the anti-arrhythmia drug procainamide. Following this need to find new demethylating agents, we have tested the potential use of procaine, an anesthetic drug related to procainamide. Using the MCF-7 breast cancer cell line, we have found that procaine is a DNA-demethylating agent that produces a 40% reduction in 5-methylcytosine DNA content as determined by high-performance capillary electrophoresis or total DNA enzyme digestion. Procaine can also demethylate densely hypermethylated CpG islands, such as those located in the promoter region of the RAR beta 2 gene, restoring gene expression of epigenetically silenced genes. This property may be explained by our finding that procaine binds to CpG-enriched DNA. Finally, procaine also has growth-inhibitory effects in these cancer cells, causing mitotic arrest. Thus, procaine is a promising candidate agent for future cancer therapies based on epigenetics.


Subject(s)
Antineoplastic Agents/pharmacology , DNA Methylation , Procaine/pharmacology , CpG Islands , DNA/metabolism , Dose-Response Relationship, Drug , Genes, Tumor Suppressor , Humans , Procaine/metabolism , Receptors, Retinoic Acid/genetics , Tumor Cells, Cultured
17.
Biochemistry ; 40(37): 11121-30, 2001 Sep 18.
Article in English | MEDLINE | ID: mdl-11551210

ABSTRACT

Long-chain alkanols are general anesthetics which can also act as uncharged noncompetitive inhibitors of the peripheral nicotinic acetylcholine receptor (AChR) by binding to one or more specific sites on the AChR. Cembranoids are naturally occurring, uncharged noncompetitive inhibitors of peripheral and neuronal AChRs, which have no demonstrable general anesthetic activity in vivo. In this study, [3H]tenocyclidine ([3H]TCP), an analogue of the cationic noncompetitive inhibitor phencyclidine (PCP), was used to characterize the cembranoid and long-chain alkanol sites on the desensitized Torpedo californica AChR and to investigate if these sites interact. These studies confirm that there is a single cembranoid site which sterically overlaps the [3H]TCP channel site. This cembranoid site probably also overlaps the sites for the cationic noncompetitive inhibitors, procaine and quinacrine. Evidence is also presented for one or more allosteric cembranoid sites which negatively modulate cembranoid affinity for the inhibitory site. In contrast, long-chain alkanols inhibit [3H]TCP binding through an allosteric mechanism involving two or more alkanol sites which display positive cooperativity toward each other. Double inhibitor studies show that the cembranoid inhibitory site and the alkanol sites are not independent of each other but interfere allosterically with each other's inhibition of [3H]TCP binding. The simplest models consistent with the observed data are presented and discussed.


Subject(s)
Anesthetics/metabolism , Diterpenes/metabolism , Fatty Alcohols/metabolism , Nicotinic Antagonists/metabolism , Receptors, Nicotinic/metabolism , Allosteric Regulation , Animals , Binding Sites , Binding, Competitive , Hexanols/metabolism , Models, Theoretical , Octanols/metabolism , Phencyclidine/metabolism , Procaine/metabolism , Torpedo
18.
Vestn Otorinolaringol ; (1): 37-9, 2001.
Article in Russian | MEDLINE | ID: mdl-11247245

ABSTRACT

An original method of buccal administration of the drugs (by means of chewing gum) was tried in 30 patients aged 18-33 years. The drugs (ketrodol--0.5 mg/kg, diazepam--0.15 mg/kg, clofelin--1 microg/kg) were used to potentiate local anesthesia in operation--submucosal resection of the nasal septum under novocain solution anesthesia. Control 15 patients were operated under local anesthesia with morphine premedication (dose 10 mg). Adequacy of anesthesia was assessed by parameters of central and peripheral hemodynamics. Local anesthesia with morphine significantly activated sympathoadrenal system. Hyperdynamia was secured at the expense of accelerated cardiac rhythm with relatively low myocardial performance. Premedication with the chewing gum allowed to avoid pressor responses to the trauma in moderate hyperdynamia with adequate cardiac performance and minimal shifts in myocardial contractility.


Subject(s)
Analgesics/pharmacology , Anesthetics, Intravenous/pharmacology , Anesthetics, Local/metabolism , Clonidine/pharmacology , Diazepam/pharmacology , Nasal Septum/surgery , Procaine/metabolism , Adolescent , Adult , Analgesics/administration & dosage , Anesthetics, Intravenous/administration & dosage , Anesthetics, Local/administration & dosage , Clonidine/administration & dosage , Diazepam/administration & dosage , Drug Synergism , Humans , Procaine/administration & dosage
19.
J Pharm Pharmacol ; 49(7): 715-20, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9255717

ABSTRACT

The interaction of amine local anaesthetics and related compounds with histamine H1 receptors was investigated in guinea-pig ileal longitudinal muscle. Quinacrine, chloroquine, tetracaine and procaine inhibited [3H]mepyramine binding to solubilized membrane from ileal muscle with pKi values of 5.27 +/- 0.11, 5.66 +/- 0.01, 4.28 +/- 0.08 and 3.97 +/- 0.11, respectively. The pKB values obtained from the initial parallel shift of the dose-response curves for histamine in the presence of these drugs were 5.49 +/- 0.11, 6.14 +/- 0.09, 4.86 +/- 0.06 and 4.58 +/- 0.06, respectively, in reasonable agreement with the pKi values. The combined dose-ratio test with both local anaesthetics and antagonist (mepyramine) present showed that tetracaine and procaine were competitive and chloroquine was partially competitive, but that quinacrine was not competitive at histamine H1 receptors. These local anaesthetics inhibited histamine-induced desensitization in guinea-pig ileum. Receptor occupancy (%) by agonist decreased from 95.2 (without inhibitor) to 73.9, 42.8, 35.9 and 33.9 in the presence of quinacrine, chloroquine, tetracaine or procaine, respectively, under the conditions where each inhibitor drug induced half maximum inhibition of desensitization. The results suggested that most of these local anaesthetics interacted competitively at histamine H1 receptors and inhibited desensitization through their antagonizing actions, whereas quinacrine interacted allosterically and inhibited desensitization through a separate action.


Subject(s)
Anesthetics, Local/metabolism , Ileum/metabolism , Muscle, Smooth/drug effects , Receptors, Histamine H1/metabolism , Anesthetics, Local/pharmacology , Animals , Binding, Competitive , Chloroquine/metabolism , Chloroquine/pharmacology , Dose-Response Relationship, Drug , Female , Guinea Pigs , Histamine/toxicity , Histamine H1 Antagonists/metabolism , Histamine H1 Antagonists/pharmacology , Ileum/drug effects , Isotope Labeling , Male , Muscle Contraction/drug effects , Procaine/metabolism , Procaine/pharmacology , Pyrilamine/metabolism , Pyrilamine/pharmacology , Quinacrine/metabolism , Quinacrine/pharmacology , Receptors, Histamine H1/drug effects , Structure-Activity Relationship , Tetracaine/metabolism , Tetracaine/pharmacology
20.
Reg Anesth ; 22(1): 43-52, 1997.
Article in English | MEDLINE | ID: mdl-9010946

ABSTRACT

BACKGROUND AND OBJECTIVES: Although 2-chloroprocaine continues to be a useful drug for epidural anesthesia in obstetrics, it has the anomalous action of decreasing the analgesic effectiveness of subsequently administered epidural fentanyl. Some investigators have suggested that 2-chloroprocaine may act at an opioid receptor site to antagonize the effects of fentanyl. The purpose of our studies was to investigate this hypothesis. METHODS: Radioligand binding assays using the mu and kappa opioid receptor-selective radioligands [3H]-DAMGO and [3H]-U69,593, respectively, were performed to determine the potencies of lidocaine, 2-chloroprocaine, and 2-chloroprocaine metabolites at the mu and kappa opioid receptor sites. Electrophysiologic experiments in in vitro hippocampal slice preparations were then used to examine the effects of 2-chloroprocaine at these opioid receptor subtypes. RESULTS: Lidocaine caused a partial reduction of [3H]-DAMGO binding, which was dose-limited owing to the solubility of lidocaine. 2-Chloroprocaine caused complete displacement of [3H]-DAMGO binding, with a median effective concentration of 1.44 +/- 0.36 mM. The EC50 values for [3H]-U69,593 displacement were 177 +/- 47 microM for 2-chloroprocaine and 2.53 +/- 0.48 mM for lidocaine. Assuming a competitive interaction between anesthetic and opioid, the Ki value for 2-chloroprocaine was 435 microM at mu receptors and 49 microM at kappa receptors. In the mu activity bioassay, 2-chloroprocaine reversed the increased neuronal excitability caused by fentanyl, but this effect was further reduced by naloxone. In addition, 2-chloroprocaine did not reverse the after depolarization caused by fentanyl. In the kappa activity bioassay, 2-chloroprocaine produced effects similar to the kappa agonist U69, 593, but these were not antagonized by naloxone. CONCLUSIONS: Although 2-chloroprocaine has binding affinity at mu and kappa opioid receptor sites, it does not appear to act through an opioid receptor to antagonize the physiologic effects of fentanyl.


Subject(s)
Analgesics, Opioid/pharmacology , Anesthetics, Local/pharmacology , Benzeneacetamides , Fentanyl/antagonists & inhibitors , Procaine/analogs & derivatives , Receptors, Opioid, kappa/drug effects , Receptors, Opioid, mu/drug effects , Analgesics/metabolism , Analgesics/pharmacology , Analgesics, Opioid/metabolism , Anesthetics, Local/metabolism , Animals , Binding, Competitive , Drug Interactions , Enkephalin, Ala(2)-MePhe(4)-Gly(5)- , Enkephalins/metabolism , Enkephalins/pharmacology , Fentanyl/metabolism , Fentanyl/pharmacology , Guinea Pigs , Hippocampus/drug effects , Hippocampus/physiology , Hippocampus/ultrastructure , Kinetics , Lidocaine/metabolism , Procaine/metabolism , Procaine/pharmacology , Pyrrolidines/metabolism , Pyrrolidines/pharmacology , Radioligand Assay , Receptors, Opioid, kappa/antagonists & inhibitors , Receptors, Opioid, kappa/metabolism , Receptors, Opioid, mu/antagonists & inhibitors , Receptors, Opioid, mu/metabolism , Tritium
SELECTION OF CITATIONS
SEARCH DETAIL
...